Satyanarayana S, Sekhar J Rajad, Kumar K Eswar, Shannika L Bacchus, Rajanna Bettaiya, Rajanna Sharada
University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, AP, India.
Mol Cell Biochem. 2006 Feb;283(1-2):123-7. doi: 10.1007/s11010-006-2387-2.
Oxidative stress is involved in diabetes mellitus and its complications. Since diabetes is a stress-related disorder, supplementation with antioxidants may improve the condition. The purpose of this study is to know the effect of oral administration of selenium on blood glucose and its influence on gliclazide induced hypoglycaemia/antihyperglycaemia in normal and alloxan-induced diabetic rats. Albino rats of either sex were divided into three groups of six each. Group-I/II/III were treated with selenium 1/2 TD (0.9 microg/200 g rat)/TD (1.8 microg/200 g rat)/2TD (3.6 microg/200 g rat), respectively. Later group II was treated with gliclazide TD (1.44 mg/200 g rat)/selenium TD + gliclazide TD with a washout period of 1 week between the treatments. Diabetes was induced by alloxan monohydrate 100 mg/kg body weight i.p. A group of six rats showing fasting blood glucose levels ranging from 175-250 mg/dl were selected for the study. Rats were treated with selenium TD, gliclazide TD and selenium TD + gliclazide TD with a washout period of 1 week between the treatments. Selenium 1/2 TD and TD produced hypoglycaemia while 2TD produced hyperglycaemia. The combination of selenium TD with gliclazide TD, significantly enhanced the glucose lowering effect of gliclazide in normal and diabetic rats.
氧化应激与糖尿病及其并发症有关。由于糖尿病是一种与应激相关的疾病,补充抗氧化剂可能会改善病情。本研究的目的是了解口服硒对血糖的影响及其对正常大鼠和四氧嘧啶诱导的糖尿病大鼠中格列齐特所致低血糖/抗高血糖作用的影响。将雌雄白化大鼠各分为三组,每组六只。第一/二/三组分别用1/2倍治疗剂量(0.9微克/200克大鼠)/治疗剂量(1.8微克/200克大鼠)/2倍治疗剂量(3.6微克/200克大鼠)的硒进行治疗。随后,第二组用格列齐特治疗剂量(1.44毫克/200克大鼠)/硒治疗剂量+格列齐特治疗剂量,两次治疗之间有1周的洗脱期。通过腹腔注射100毫克/千克体重的一水合四氧嘧啶诱导糖尿病。选择一组空腹血糖水平在175 - 250毫克/分升之间的六只大鼠进行研究。大鼠分别用硒治疗剂量、格列齐特治疗剂量以及硒治疗剂量+格列齐特治疗剂量进行治疗,两次治疗之间有1周的洗脱期。1/2倍治疗剂量和治疗剂量的硒产生低血糖,而2倍治疗剂量的硒产生高血糖。硒治疗剂量与格列齐特治疗剂量联合使用,显著增强了格列齐特对正常大鼠和糖尿病大鼠的降糖作用。